Babylon Holdings Limited - Revision history

85.247.79.245: /* Risk */

2023-07-28T09:55:20Z

Risk

← Older revision		Revision as of 10:55, 28 July 2023
Line 154:		Line 154:

	Another risk Babylon faces is with the efficacy of their platform. With limited AI funding and some reviews questioning the impact and value of their service Babylon can come under scrutiny if proven to be ineffective. To mitigate this, funding is needed to constantly evolve and improve their software and fix any outstanding errors. A risk related to this is whether Babylon's service is creating value to the correct target groups. Some criticism form NHS practitioners has suggested Babylon's model using new technology may attract the wrong customer base. Some have said their service may be counter productive since younger healthier individuals are using the app and gaining NHS referrals when they are mostly healthy. This is wasting valuable NHS time an resourcing through directing care away from those who may be older and need this service more prominently, to those who would not have otherwise used NHS services for a smaller illness as Babylon's platform makes this easier to do so.		Another risk Babylon faces is with the efficacy of their platform. With limited AI funding and some reviews questioning the impact and value of their service Babylon can come under scrutiny if proven to be ineffective. To mitigate this, funding is needed to constantly evolve and improve their software and fix any outstanding errors. A risk related to this is whether Babylon's service is creating value to the correct target groups. Some criticism form NHS practitioners has suggested Babylon's model using new technology may attract the wrong customer base. Some have said their service may be counter productive since younger healthier individuals are using the app and gaining NHS referrals when they are mostly healthy. This is wasting valuable NHS time an resourcing through directing care away from those who may be older and need this service more prominently, to those who would not have otherwise used NHS services for a smaller illness as Babylon's platform makes this easier to do so.

			'''Risk summary'''

			* Operations are dependent on physician owned entities so a damage to those relationships will drastically effect Babylon’s operational ability
			* Significant portion of Babylon’s revenue is coming from a small number of customers. This leaves Babylon very dependant and therefore vulnerable to this group. If opinions change, a huge revenue source will be lost immediately.
			* Babylon’s move to go private without paying shareholders could negatively impact sentiment towards the firm. This could result in long term damage to the company’s reputation which could negatively affect its growth prospects.
			* Babylon’s move to go private is in place to restructure the business which is currently accumulating losses. If the company restructuring fails to have the desired effect, Babylon could continue to be unprofitable until eventually, available funding dries up.
			* The healthcare industry is a heavily regulated industry, with many licenses and authorisations required for participation. If any of these are lost, Babylon’s may lose the right to operate some its services, ending revenue streams and preventing Babylon from being able to grow in the market.

	== ESG ==		== ESG ==

>Hannaa: /* Risk */

2023-07-28T09:45:26Z

Risk

← Older revision		Revision as of 10:45, 28 July 2023
Line 145:		Line 145:

	== Risk ==		== Risk ==
			In March and May of 2023, Babylon Health initiated two lines of credit, referred to as the Bridge Facility and the Additional Bridge Facility. These agreements came with restrictive debt covenants, which are stringent conditions. In addition, Babylon Health is planning to execute certain transactions according to a strategy to privatize the company, as laid out in the Framework Agreement. However, these plans may be modified if satisfactory proposals from third parties surface during this interim period.

			It is important to note, however, that there are no guarantees that the Additional Bridge Facility and the Framework Agreement will be implemented in a way that secures Babylon Health's necessary funding. It is also possible that Babylon Health may not be able to acquire additional financing, or if they do, it might not be on terms that are favorable to them. If these transactions are carried out, they have the potential to significantly dilute, or even completely wipe out, the economic interests of Babylon Health's shareholders. This could subsequently result in a change in the company's ownership or control.

			Babylon Health previously financed their operations through the sale of their equity securities, revenue from operations and debt financing. They had $338.7 million of indebtedness as of March 31 2023. Babylon holdings have risks associated with financing their operations and despite high growth rates remain in net loss, and continued debt. They require additional funding, which has created significant doubts on whether they will be able to receive this funding as they continue over the next 12 months.

			To aim to combat their financial worries they are considering strategic alternatives, including restructuring or refinancing debt, seeking additional debt or equity capital, selling assets or other measures such as putting Babylon into administration under UK law. This will also face risks and uncertainties in executing their business plan until this alternative strategy has been implemented.

			Another risk Babylon faces is with the efficacy of their platform. With limited AI funding and some reviews questioning the impact and value of their service Babylon can come under scrutiny if proven to be ineffective. To mitigate this, funding is needed to constantly evolve and improve their software and fix any outstanding errors. A risk related to this is whether Babylon's service is creating value to the correct target groups. Some criticism form NHS practitioners has suggested Babylon's model using new technology may attract the wrong customer base. Some have said their service may be counter productive since younger healthier individuals are using the app and gaining NHS referrals when they are mostly healthy. This is wasting valuable NHS time an resourcing through directing care away from those who may be older and need this service more prominently, to those who would not have otherwise used NHS services for a smaller illness as Babylon's platform makes this easier to do so.

	== ESG ==		== ESG ==

85.247.79.245: /* Risk */

2023-07-28T09:29:52Z

Risk

← Older revision		Revision as of 10:29, 28 July 2023
Line 112:		Line 112:

	== Stock Price Timeline and Explanation ==		== Stock Price Timeline and Explanation ==
	~~[Insert company timeline]~~		Having successfully completed series A, B and C funding, worth $25mn, $60mn and $550mn respectively, in the six years following its birth, Babylon was taken public in the final quarter of 2021. Babylon made the decision to divert from the traditional Investment Bank IPO route and instead chose to look in the direction of SPACs.

	Having successfully completed series A, B and C funding, worth $25mn, $60mn and $550mn respectively, in the six years following its birth, Babylon was taken public in the final quarter of 2021. Babylon made the decision to divert from the traditional Investment Bank IPO route and instead chose to look in the direction of SPACs.

	'''Public listing (October 2020)'''		'''Public listing (October 2020)'''
Line 135:		Line 133:

	'''Announcement of planned delisting from stock exchange (May 2023''')		'''Announcement of planned delisting from stock exchange (May 2023''')

	~~Add stock price response~~



	'''Other factors influencing share price'''		'''Other factors influencing share price'''

Manos at 09:28, 28 July 2023

2023-07-28T09:28:15Z

← Older revision		Revision as of 10:28, 28 July 2023
Line 160:		Line 160:

	Babylon Health aims to make healthcare accessible and affordable the world over, through building specialised health services for those countries with little or no access to basic health care. They are doing this through creating partnerships across the world in countries with limited access to basic healthcare. Babyl Rwanda is their notable partnership that provides healthcare services in Rwanda. Rwanda was struggling with easily accessible and affordable healthcare. In an effort to address this issue, in 2016 Babylon Health partnered with the Government of Rwanda and the Bill & Melinda Gates Foundation to offer Rwandans one of the most progressive solutions in healthcare. Their service, under the local name Babyl, is integrated into Rwanda’s National Health Insurance Scheme and is the largest digital health provider in the country.		Babylon Health aims to make healthcare accessible and affordable the world over, through building specialised health services for those countries with little or no access to basic health care. They are doing this through creating partnerships across the world in countries with limited access to basic healthcare. Babyl Rwanda is their notable partnership that provides healthcare services in Rwanda. Rwanda was struggling with easily accessible and affordable healthcare. In an effort to address this issue, in 2016 Babylon Health partnered with the Government of Rwanda and the Bill & Melinda Gates Foundation to offer Rwandans one of the most progressive solutions in healthcare. Their service, under the local name Babyl, is integrated into Rwanda’s National Health Insurance Scheme and is the largest digital health provider in the country.

			== References ==

95.149.161.192 at 09:25, 28 July 2023

2023-07-28T09:25:17Z

← Older revision		Revision as of 10:25, 28 July 2023
Line 1:		Line 1:
	== ~~Summary~~ ==		{{Infobox company
			\| name = Babylon Health
			\| logo = Babylon-health-logo.png
			\| traded_as = {{NYSE\|BBLN}}
			\| founded = {{Start date\|2013}}
			\| founder = [[Ali Parsa]]
			\| industry = [[Health care]]
			\| revenue = {{US$\|322.9 million}}<ref>{{cite web\|url=https://www.valdostadailytimes.com/news/business/babylon-delivers-four-fold-revenue-growth-in-2021-and-on-track-to-meet-three-fold/article_e0a23dcb-9a4c-5a34-aa2f-127894d16f81.html\|title=Babylon Delivers Four-Fold Revenue Growth in 2021 and On Track to Meet Three-Fold 2022 Revenue Growth to up to $1 Billion \|publisher= bailii.org \|access-date=10 March 2022}}</ref>
			\| revenue_year = 2021
			\| num_employees = 2,189<ref>{{cite web\|url=https://www.owler.com/company/babylonhealth \|title=Babylon \|publisher=owler.com \|access-date=7 December 2021}}</ref>
			\| num_employees_year = 2021
			\| homepage = {{URL\|https://www.babylonhealth.com}}
			\| location_city = London, United Kingdom
			}}

	Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.		Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.

>Hannaa: /* ESG */

2023-07-28T09:24:38Z

ESG

← Older revision		Revision as of 10:24, 28 July 2023
Line 142:		Line 142:
	ESG is central to Babylon's mission to make quality healthcare accessible and affordable to every person on Earth. Their initial merger with AlbaCore Group had sustainability at the forefront of the deal. AlbaCore Group made a sustainability-linked investment of $200 million in Babylon Holdings Limited.		ESG is central to Babylon's mission to make quality healthcare accessible and affordable to every person on Earth. Their initial merger with AlbaCore Group had sustainability at the forefront of the deal. AlbaCore Group made a sustainability-linked investment of $200 million in Babylon Holdings Limited.

	Although a somewhat limited ESG ~~focus~~ throughout the company, it's clear sustainability is at the forefront of their mission and product service offering. The key aim of allowing wider access to healthcare with lower costs for consumers.		Although a somewhat limited ESG management throughout the company reports, it's clear sustainability is at the forefront of their mission and product service offering. The key aim of allowing wider access to healthcare with lower costs for consumers.

	Babylon Health has partnerships with the NHS. Notable trusts within the NHS that have partnered with Babylon include the Royal Wolverhampton NHS Trust that announced a 10-year partnership with Babylon in January 2020. This partnership had the aim of developing a new model of digital-first integrated care and was followed by the introduction of a Covid-19 care assistant in April 2020. This partnership was extended to primary care in August 2021 which saw the roll out of the Babylon 360 app. Babylon Health aims to expand this part of their business aiming to combat the 'overwhelming demand' for GP services in the UK since the pandemic.		Babylon Health has partnerships with the NHS. Notable trusts within the NHS that have partnered with Babylon include the Royal Wolverhampton NHS Trust that announced a 10-year partnership with Babylon in January 2020. This partnership had the aim of developing a new model of digital-first integrated care and was followed by the introduction of a Covid-19 care assistant in April 2020. This partnership was extended to primary care in August 2021 which saw the roll out of the Babylon 360 app. Babylon Health aims to expand this part of their business aiming to combat the 'overwhelming demand' for GP services in the UK since the pandemic.

	Babylon Health aims to make healthcare accessible and affordable the world over, through building specialised health services for those countries with little or no access to basic health care. They are doing this through creating partnerships across the world in countries with limited access to basic healthcare. Babyl Rwanda is their notable partnership that provides healthcare services in Rwanda. Rwanda was struggling with easily accessible and affordable healthcare. In an effort to address this issue, in 2016 Babylon Health partnered with the Government of Rwanda and the Bill & Melinda Gates Foundation to offer Rwandans one of the most progressive solutions in healthcare. Their service, under the local name Babyl, is integrated into Rwanda’s National Health Insurance Scheme and is the largest digital health provider in the country.		Babylon Health aims to make healthcare accessible and affordable the world over, through building specialised health services for those countries with little or no access to basic health care. They are doing this through creating partnerships across the world in countries with limited access to basic healthcare. Babyl Rwanda is their notable partnership that provides healthcare services in Rwanda. Rwanda was struggling with easily accessible and affordable healthcare. In an effort to address this issue, in 2016 Babylon Health partnered with the Government of Rwanda and the Bill & Melinda Gates Foundation to offer Rwandans one of the most progressive solutions in healthcare. Their service, under the local name Babyl, is integrated into Rwanda’s National Health Insurance Scheme and is the largest digital health provider in the country.

>Hannaa: /* ESG */

2023-07-28T09:23:08Z

ESG

← Older revision		Revision as of 10:23, 28 July 2023
Line 14:		Line 14:

	== Product Offering and Services ==		== Product Offering and Services ==

			Babylon delivers millions of clinical consultations and AI interactions to patients across the globe. Their aim is to allow patients to experience better health at reduced costs. This is achieved by leveraging a highly scalable, digital-first platform combined with high quality, virtual clinical operations to provide integrated, personalized healthcare. They endeavor to support patients’ health needs, all from their devices, with the aim to promote longer and healthier lives. When sick, Babylon provides assistance to navigate the health system, connecting patients digitally to the right clinician 24/7, at no additional cost.

	'''Business Model'''		'''Business Model'''
Line 138:		Line 140:

	== ESG ==		== ESG ==
			ESG is central to Babylon's mission to make quality healthcare accessible and affordable to every person on Earth. Their initial merger with AlbaCore Group had sustainability at the forefront of the deal. AlbaCore Group made a sustainability-linked investment of $200 million in Babylon Holdings Limited.

			Although a somewhat limited ESG focus throughout the company, it's clear sustainability is at the forefront of their mission and product service offering. The key aim of allowing wider access to healthcare with lower costs for consumers.

			Babylon Health has partnerships with the NHS. Notable trusts within the NHS that have partnered with Babylon include the Royal Wolverhampton NHS Trust that announced a 10-year partnership with Babylon in January 2020. This partnership had the aim of developing a new model of digital-first integrated care and was followed by the introduction of a Covid-19 care assistant in April 2020. This partnership was extended to primary care in August 2021 which saw the roll out of the Babylon 360 app. Babylon Health aims to expand this part of their business aiming to combat the 'overwhelming demand' for GP services in the UK since the pandemic.

			Babylon Health aims to make healthcare accessible and affordable the world over, through building specialised health services for those countries with little or no access to basic health care. They are doing this through creating partnerships across the world in countries with limited access to basic healthcare. Babyl Rwanda is their notable partnership that provides healthcare services in Rwanda. Rwanda was struggling with easily accessible and affordable healthcare. In an effort to address this issue, in 2016 Babylon Health partnered with the Government of Rwanda and the Bill & Melinda Gates Foundation to offer Rwandans one of the most progressive solutions in healthcare. Their service, under the local name Babyl, is integrated into Rwanda’s National Health Insurance Scheme and is the largest digital health provider in the country.

85.247.79.245: /* Stock Price Timeline and Explanation */

2023-07-28T00:17:06Z

Stock Price Timeline and Explanation

← Older revision		Revision as of 01:17, 28 July 2023
Line 131:		Line 131:
	Babylon’s poor stock performance since its first listing in October 2021 can also be put down to the over inflated state of the telemedicine market at the time. During the pandemic, digitisation within the healthcare industry accelerated sharply, driven by the need to access patients who were forced into self-isolation. In a world where a return to pre-covid life seemed only imaginary, the telemedicine industry was in the forefront of investors’ minds, with Matt Hancock even describing Babylon’s services as “revolutionary”.		Babylon’s poor stock performance since its first listing in October 2021 can also be put down to the over inflated state of the telemedicine market at the time. During the pandemic, digitisation within the healthcare industry accelerated sharply, driven by the need to access patients who were forced into self-isolation. In a world where a return to pre-covid life seemed only imaginary, the telemedicine industry was in the forefront of investors’ minds, with Matt Hancock even describing Babylon’s services as “revolutionary”.

	However, as the world recovered from the pandemic, the rate of healthcare digitisation slowed as it became less of a pressing concern to many people. Having listed on the NYSE near the peak of this focus, investment into Babylon’s public equity only had room to fall as telemedicine expectations dropped to pre-covid levels. Additionally, the stock market started to peak in October 2021 before a long downward trend, driven by ~~first~~ the Omicron variant and then later an extremely volatile geopolitical climate, along with monetary and fiscal contraction in response to soaring inflation.		However, as the world recovered from the pandemic, the rate of healthcare digitisation slowed as it became less of a pressing concern to many people. Having listed on the NYSE near the peak of this focus, investment into Babylon’s public equity only had room to fall as telemedicine expectations dropped to pre-covid levels. Additionally, the stock market started to peak in October 2021 before a long downward trend, driven first by the Omicron variant and then later an extremely volatile geopolitical climate, along with monetary and fiscal contraction in response to soaring inflation.

	''Target market not reached''		''Target market not reached''

85.247.79.245: /* Stock Price Timeline and Explanation */

2023-07-28T00:16:33Z

Stock Price Timeline and Explanation

← Older revision		Revision as of 01:16, 28 July 2023
Line 131:		Line 131:
	Babylon’s poor stock performance since its first listing in October 2021 can also be put down to the over inflated state of the telemedicine market at the time. During the pandemic, digitisation within the healthcare industry accelerated sharply, driven by the need to access patients who were forced into self-isolation. In a world where a return to pre-covid life seemed only imaginary, the telemedicine industry was in the forefront of investors’ minds, with Matt Hancock even describing Babylon’s services as “revolutionary”.		Babylon’s poor stock performance since its first listing in October 2021 can also be put down to the over inflated state of the telemedicine market at the time. During the pandemic, digitisation within the healthcare industry accelerated sharply, driven by the need to access patients who were forced into self-isolation. In a world where a return to pre-covid life seemed only imaginary, the telemedicine industry was in the forefront of investors’ minds, with Matt Hancock even describing Babylon’s services as “revolutionary”.

	However, as the world recovered from the pandemic, the rate of healthcare digitisation slowed as it became less of a pressing concern to many people. Having listed on the NYSE near the peak of this focus, investment into Babylon’s public equity only had room to fall as telemedicine expectations dropped to pre-covid levels. Additionally, the stock market started to peak in October 2021 before a long downward trend, driven by an extremely volatile geopolitical climate, along with monetary and fiscal contraction in response to soaring inflation.		However, as the world recovered from the pandemic, the rate of healthcare digitisation slowed as it became less of a pressing concern to many people. Having listed on the NYSE near the peak of this focus, investment into Babylon’s public equity only had room to fall as telemedicine expectations dropped to pre-covid levels. Additionally, the stock market started to peak in October 2021 before a long downward trend, driven by first the Omicron variant and then later an extremely volatile geopolitical climate, along with monetary and fiscal contraction in response to soaring inflation.

	''Target market not reached''		''Target market not reached''

>Hannaa: /* Team */

2023-07-28T00:08:23Z

Team

← Older revision		Revision as of 01:08, 28 July 2023
Line 55:		Line 55:
	'''Board of Directors'''		'''Board of Directors'''

	Eugene I. Davis ~~Mairi Johnson David Warren Aidan de Brunner~~		Eugene I. Davis: ''Director''

	''<small>~~Director~~ Chief Partnerships Officer and Director Director Director</small>''		Mairi Johnson: ''<small>Chief Partnerships Officer and Director</small>''

			David Warren: ''<small>Director</small>''

			Aidan de Brunner: ''<small>Director</small>''

	== Valuations and Financials ==		== Valuations and Financials ==